My ePortfolio Register   

Personalising breast cancer therapies

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 23.03.17
Views: 894

Dr Philip Poortmans - Institut Curie, Paris, France

Dr Poortmans speaks with ecancer at the 2017 St. Gallen International Breast Cancer Conference about maturing data from recent clinical trials.

He highlights the improved outcomes of breast conservation and radiotherapy after lumpectomy as results whose significance is now becoming apparent, and discusses the role of surgery in managing breast cancer, as presented by Dr Monica Morrow.

Dr Poortmans also considers the timing of radiotherapy for breast cancer, with conference presentations weighing intra-operative and post-operative radiotherapy.

Overall, he describes the need for collaboration and personalisation of treatment to patients, aiming always for the maximum benefit with the minimum impact on quality of life.

Related videos

follow us

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence